Ginkgo Bioworks Holdings Inc. Revenue 2019–2025
Ginkgo Bioworks Holdings Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ginkgo Bioworks Holdings Inc. revenue for the quarter ending March 31, 2026 was 19.5 M, a 49.06% decrease year-over-year.
- Ginkgo Bioworks Holdings Inc. revenue for the twelve months ending March 31, 2026 was 146.1 M, a 38.76% decrease year-over-year.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2025 was 170.2 M, a 25.06% decrease from 2024.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2024 was 227.0 M, a 9.71% decrease from 2023.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2023 was 251.5 M, a 47.36% decrease from 2022.
- Ginkgo Bioworks Holdings Inc. annual revenue for 2022 was 477.7 M.
Ginkgo Bioworks Holdings Inc. (DNA) — Frequently Asked Questions
Ginkgo Bioworks Holdings Inc. (DNA) is a publicly traded US company. It has a market capitalization of $440M. In fiscal 2025 it reported revenue of $170M and net income of -$313M. Explore DNA's stock price, financial statements, earnings history, margins and key ratios below.
What is Ginkgo Bioworks Holdings Inc.'s market cap?
Ginkgo Bioworks Holdings Inc. (DNA) has a market capitalization of $440M.
What is the DNA stock price?
DNA trades at $7.94 (-3.76% on the day).
How much revenue does Ginkgo Bioworks Holdings Inc. make?
Ginkgo Bioworks Holdings Inc. reported revenue of $170M in fiscal 2025.
Is DNA profitable?
In fiscal 2025, Ginkgo Bioworks Holdings Inc. reported net income of -$313M.